Schedule of Derivative Financial Instruments |
Information about our derivative financial instruments at March 31, 2025 and December 31, 2024 is as follows (dollars in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Notional Amount | | Fair Value | Contract date | | Effective Date | | Expiration Date | | Average Annual Effective Fixed Rate | | March 31, 2025 | | December 31, 2024 | | March 31, 2025 | | December 31, 2024 | Operating Partnership: | | | | | | | | | | | | | | | | | | | | | | | | | | June 11, 2018 | | December 31, 2018 | | December 31, 2025 | | 2.92 | % | | $ | 125,000 | | | $ | 125,000 | | | $ | 1,117 | | | $ | 1,582 | | July 26, 2022 | | January 31, 2023 | | January 31, 2027 | | 2.60 | % | | 100,000 | | | 100,000 | | | 1,941 | | | 2,824 | | July 26, 2022 | | January 31, 2023 | | January 31, 2029 | | 2.56 | % | | 100,000 | | | 100,000 | | | 3,669 | | | 5,325 | | Total Operating Partnership | | | | | | 325,000 | | | 325,000 | | | 6,727 | | | 9,731 | | | | | | | | | | | | | | | | | GIC Joint Venture: | | | | | | | | | | | March 24, 2023 | | July 1, 2023 | | January 13, 2026 | | 3.35 | % | | 100,000 | | | 100,000 | | | 500 | | | 754 | | March 24, 2023 | | July 1, 2023 | | January 13, 2026 | | 3.35 | % | | 100,000 | | | 100,000 | | | 500 | | | 754 | | January 19, 2024 | | October 1, 2024 | | January 13, 2026 | | 3.77 | % | | 100,000 | | | 100,000 | | | 179 | | | 334 | | | | | | | | | | | | | | | | | Total GIC Joint Venture | | | | | | 300,000 | | | 300,000 | | | 1,179 | | | 1,842 | | Total | | 3.09 | % | (1) | $ | 625,000 | | | $ | 625,000 | | | $ | 7,906 | | | $ | 11,573 | |
(1) Represents the weighted-average effective interest rate of our current interest rate swaps at March 31, 2025.
|
Schedule of Location in Financial Statements of Gain or Loss Recognized on Derivative Financial Instruments Designated as Cash Flow Hedges |
We characterize the realized and unrealized gain or loss related to derivative financial instruments designated as cash flow hedges as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | | 2025 | | 2024 | | | | | Unrealized (loss) gain recognized in Accumulated other comprehensive income (loss) on derivative financial instruments | | $ | (1,698) | | | $ | 9,375 | | | | | | Gain reclassified from Accumulated other comprehensive income to Interest expense | | $ | 1,969 | | | $ | 3,679 | | | | | | Total interest expense and other finance expense presented on the Condensed Consolidated Statements of Operations in which the effects of cash flow hedges are recorded | | $ | 19,956 | | | $ | 21,582 | | | | | | | | | | | | | | |
|